Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.75 GBX | 0.00% | -6.25% | -53.12% |
Apr. 26 | Evgen Pharma plc will Change its Ticker to TCF from EVG | CI |
Apr. 26 | Evgen Pharma plc will Change its Name to TheraCryf plc | CI |
Chart calendar Theracryf Plc
Upcoming events on Theracryf Plc
Past events on Theracryf Plc
2024-04-04 05:00 am | Shareholders Meeting |
2024-03-20 06:00 am | Acquisition of Chronos Therapeutics Limited by Evgen Pharma Plc Call |
2024-01-07 | JPMorgan Healthcare Conference |
2023-11-13 | Jefferies London Healthcare Conference |
2023-11-13 08:45 am | LSX Inv€$stival Showcase |
2023-10-31 03:00 am | Q2 2024 Earnings Release |
2023-07-20 11:00 am | Investor Meeting |
2023-07-20 09:00 am | Annual General Meeting |
2023-06-07 02:00 am | Q4 2023 Earnings Release |
2023-03-23 10:00 am | SFX-01 Phase 1b Study Results Call |
2023-03-22 | Proactive One2One Investor Forum |
2022-12-08 09:00 am | Interim 2023 Earnings Call |
2022-12-08 02:00 am | Interim 2023 Earnings Release |
2022-10-12 08:00 am | Investor Meeting |
2022-07-21 10:30 am | Investor Meeting |
2022-07-21 09:00 am | Annual General Meeting |
2022-06-08 02:00 am | FY 2022 Earnings Release |
2021-12-07 02:00 am | Interim 2022 Earnings Release |
2021-07-13 09:00 am | Annual General Meeting |
2021-06-15 02:00 am | FY 2021 Earnings Release |
Annual results
Fiscal Period | Marzo | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,27 0,27 0.27% | 0,00 0,00 - | 0,55 0,61 -9.46% | 0,49 |
EBITDA Million USD | Released Forecast Spread | -3,94 -4,29 8.1% | -3,95 -4,34 8.93% | -4,51 -5,05 10.71% | -4,00 -6,42 37.75% | -6,32 -4,72 -33.78% | -4,98 |
EBIT Million USD | Released Forecast Spread | -3,97 -4,29 7.48% | -3,97 -4,34 8.33% | -4,53 -5,19 12.56% | -4,02 -6,40 37.29% | -6,34 -4,72 -34.12% | -4,98 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,97 -4,55 12.76% | -3,97 -4,60 13.57% | -4,53 -5,32 14.79% | -3,99 -6,55 39.11% | -6,21 -4,97 -25.14% | -5,10 |
Net income Million USD | Released Forecast Spread | -3,34 -3,90 14.41% | -3,41 -3,94 13.52% | -3,77 -4,50 16.21% | -3,43 -5,54 38% | -5,02 -4,24 -18.4% | -4,37 |
EPS USD | Released Forecast Spread | -0,03 -0,04 13.49% | -0,03 -0,03 12.74% | -0,03 -0,03 14.46% | -0,01 -0,02 38.03% | -0,02 -0,02 -15.87% | -0,02 |
Announcement Date | 13/06/19 | 15/06/20 | 15/06/21 | 08/06/22 | 07/06/23 | - |
Today 11:00 am | GENMAB A/S: Q1 2024 Earnings Release |
Today 04:01 pm | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
2024-05-05 | FRAZIER LIFESCIENCES ACQUISITION CORPORATION: Q1 2024 Earnings Release (Projected) |
2024-05-05 | KRYSTAL BIOTECH, INC.: Q1 2024 Earnings Release |
2024-05-05 | MERUS N.V.: Q1 2024 Earnings Release (Projected) |
2024-05-05 | VAXCYTE, INC.: Q1 2024 Earnings Release (Projected) |
2024-05-05 | INHIBRX, INC.: Q1 2024 Earnings Release (Projected) |
2024-05-05 | BIONTECH SE: Q1 2024 Earnings Release |
2024-05-06 07:00 am | BIOCRYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
2024-05-06 04:01 pm | VERTEX PHARMACEUTICALS INCORPORATED: Q1 2024 Earnings Release |
Past sector events for Theracryf Plc
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- EVG Stock
- Calendar Theracryf Plc